BMO raises IBM stock price target to $265 on software outlook
BMO Capital raised IBM's price target to $265 from $230, citing strong revenue growth but noting weak organic software growth. IBM's stock trades at $246.87, with a PEG ratio of 0.27. The company reported Q3 2026 earnings of $2.95 per share on $17.1B revenue, beating estimates. IBM raised its free cash flow guidance and adjusted its software growth outlook.
How this was made
The 30-second read
Why it matters
Analyst upgrades and higher price targets suggest a bullish short‑term outlook for IBM.
Market read
IBM's earnings beat and upgraded targets provide a fresh catalyst for traders.
What to watch
Potential headwinds from competitive pressure in cloud and AI services could limit upside.
Background
IBM reported Q3 2026 revenue of $17.1 bn and EPS of $2.95, beating estimates, and raised free cash flow guidance.
Ticker impact
BMO raised IBM's price target to $265 after IBM reported Q3 2026 earnings that beat revenue and EPS estimates and raised free cash flow guidance.
likely upward pressure as the market prices in the higher price targets and earnings beat.
Earnings beat and multiple analysts raising targets indicate improved growth outlook, supporting a price rally.
Market effects
Positive for the technology and enterprise software sector as IBM's software growth outlook improves.
U.S. tech stocks may see modest gains following IBM's earnings beat.
IBM's results could influence global enterprise IT spending trends.
Counterpoint
If IBM's organic software growth remains weak, the price targets may be overly optimistic.
Key entities
- companyIBM
International Business Machines, US‑listed technology company.
- analystBMO Capital
Investment firm that raised IBM's price target.


